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Rationale and objective
Women who are invited for breast cancer screening should get enough information about the 
benefits and harms of screening to make an informed decision on participation.  Personal 
invitations are an important source of information as all invited women receive them. The objective 
was to evaluate the information breast cancer screening units send to women invited for screening 
in Finland. 
Materials and Methods
A questionnaire was sent to all breast cancer screening units in 2005 and in 2008 in Finland and 
the information (e.g. invitations, result letters, leaflets) the units sent to women were collected. 
Results from 2005 were sent as feedback to the units. Data were analysed descriptively and results 
from the two years were compared.
Results
Screening units sent personal invitation letters usually providing a fixed appointment time. Most 
units informed about participation free of charge and benefits of detecting breast cancer early. 
Harms associated with screening were seldom mentioned; no unit presented the possibilities of 
false negative results or over-treatment. 
Conclusion
The screening units provided very variable information which often was biased towards optimizing 
participation.  The high participation rate (approximately 88%) in Finland may partly be due to the 
prescriptive nature of the invitation letters. National templates for information letters would be 
useful.
Keywords: Breast cancer, Screening, Invitation, Informed consent
Personal invitations for population-based breast cancer screening 
Ulla Saalasti-Koskinen
M.Sc., Research Officer
THL (National Institute for Health and Welfare) / Finohta (Finnish Office for Health Technology 
Assessment)
P.O.Box 30, FI-00271 Helsinki
Finland
tel. +358 20 6107678
fax. +358 20 6107278
ulla.saalasti-koskinen@thl.fi
Marjukka Mäkelä
Research Professor, MD, PhD, M.Sc.
THL / Finohta
Helsinki, Finland
Irma Saarenmaa
MD, Radiologist
Chief Physician of Breast Cancer Screening Unit
Tampere, Finland
Ilona Autti-Rämö
Chief of Health Research, Associate Professor, MD, PhD
Social Insurance Institution / Research Department
Helsinki, Finland
Annotated Revised Manuscript
1Text
Background
Breast cancer screening programme aims at reducing mortality from breast cancer. Mammography 
screening can detect tumours at a preclinical stage, providing possibility for early treatment of 
cancer. Earlier diagnosis may improve the prognosis and reduce need for invasive treatment. The 
limitations of mammography screening include false-positive and false-negative mammograms, 
over-diagnosis, increased anxiety for screened women, and harms from radiation.
In Finland, legislation requires municipalities to arrange breast cancer screening biannually for
women aged 50-69. The nationwide screening started gradually for women aged 50-59 in 1987 and
covered the whole country in early 1990s. In 2006 the screening programme was expanded to 
include women 60-69 years of age. The screening and further investigations are free of charge for 
all participants. Municipalities can provide screening in their own screening unit or purchase it from 
commercial providers. The screening centres in Finland partly fulfil the process criteria given in the 
guidelines of the European Community (Table 1). 
In many countries, information concerning screening mammography presented on websites and 
screening invitations is insufficient (1). According to Finnish legislation, women invited for breast 
cancer screening should obtain adequate information about the benefits and harms of screening in 
order to make an informed decision about participation. Personal invitations are an important source 
of information, as the entire target group receive these. In Finland, municipalities have autonomy 
over the screening process of administering population-based cancer screening. They are 
responsible for ensuring the quality of the screening process, including the content of invitations
and letters notifying women of a normal or abnormal result. 
* Annotated Revised Manuscript
2We sought to evaluate the content of screening mammography invitations and result notification 
letters across the country to assess the sufficiency of information provided. 
Methods  
The Finnish Office for Health Technology Assessment (Finohta) surveyed the information offered 
by the screening units to women invited to mammography screening in Finland as part of an HTA 
report (2). In September 2005, we mailed an inquiry to all breast cancer screening units in Finland, 
using addresses received from the Finnish cancer registry. A reminder was sent to units which didn't 
answer to the first letter. The units were asked to send us their invitation and result letters and all 
other information offered at different stages to persons invited for screening. 
We informed the screening units about their practices by sending them the HTA report which 
included the results of the 2005 survey (2) with a personal cover letter. The main results were also 
published in the newsletter for radiographers and Finohta’s newsletter Impakti for municipal 
decision-makers. 
The survey was updated in November 2008. The National Screening Board at the Ministry of 
Welfare and Health requested this update to evaluate changes in the content of invitations. The 
inquiry was sent in a similar manner as before to all screening units.
We evaluated the information policy of screening units by analysing the invitation letters for 
screening and for further investigations (additional mammography, ultrasound, fine needle biopsy, 
surgery), as well as the letters informing about results. We looked for items describing the 
3implementation and effectiveness of screening, and questions about risk factors and symptoms. We 
also asked about the invitation method the units used (e.g. open invitation without date or invitation 
with a fixed appointment time), methods they used to invite for further investigations (e.g. phone 
call or invitation letter), about differences in invitations for the first screen and the subsequent 
screens, and whether the units sent reminders. We classified the contents (effectiveness of breast 
cancer screening, methods of screening, questions about breast symptoms) and listed the items 
mentioned. We analysed the data using frequencies and did a qualitative analysis of the open 
questions. This article focuses on the invitations and normal result letters.
Results 
Over a decade, the screening technology has changed from conventional screen-film to digital 
mammography. This resulted in some changes of providers in Finland: there are fewer municipal 
screening units while the number of private screening units has increased. 
The inquiry was sent to all breast cancer screening units in Finland. In 2005 we sent the inquiry to 
27 units and received answers from 23 units (85%), 10 of these after one reminder. In 2008, all 26 
units responded, 12 after the reminder. They also sent information materials as requested (Table 2).
Invitation letters
In 2005 all screening units and in 2008 all but two units sent a personal invitation letter with a fixed 
appointment time. All units sent similar invitation letters both for women invited for the first time 
and for subsequent screenings. In 2005 four units (17%) and in 2008 two units (7%) sent a detailed 
information leaflet on screening mammography when inviting women for the screening programme 
for the first time. The contents of the invitation letters are summarised in the table 3.  
4In 2005 every fourth screening unit (26%) and in 2008 15% of screening units mentioned in their 
invitation the prevalence of breast cancer. The prevalence was usually given without numbers, as 
“high” or “most common”. Many invitation letters included questions about symptoms suggestive 
of breast cancer, for example lumps (in 2005 65%, in 2008 77%), leakage (61% vs. 69%), previous 
operations (65% vs.73%), and previous breast cancer (57% vs.62%). In 2005, 57% of the screening 
units asked if the woman used hormonal treatment, while in 2008 most units (81%) asked about this
and every third unit had additional questions about the therapy (product used and duration).
Almost all screening units’ invitations told that the participation is free of charge. Most units 
remarked that screening enables an early detection of breast cancer and that women participating in 
screening have better prognosis (see table 3). The effectiveness of screening was rarely mentioned; 
only 17% of the invitation letters in 2005 informed about the positive predictive value and 
specificity of mammography screening. Three years later, positive predictive value and specificity 
were given by two letters only (7% of units). In 2005, letters often specified that benign lesions can 
be found in the screening mammography (74%), but three years later less than half of the units 
(42%) referred to this.  The possibility of a false negative result was not mentioned any invitation 
letter either year. Harms related to breast cancer screening were seldom mentioned; in 2005, four 
invitation letters (17%) told that mammography may be painful and in 2008 only three units (12%). 
The most important harms – overdiagnosis and overtreatment – were not mentioned in any 
invitation letter either year. 
Result letters
Women were usually informed about a normal result by letter. In 2008, one screening unit didn't 
send normal result letters at all, but called only those who were invited for further investigations. 
Most letters (96%) simply stated ‘no sign of cancer has been found’. The women were encouraged 
5to undertake regular breast self-examination (in 2005 96%, in 2008 92%) and to see a doctor if any 
unusual symptoms occur (100% vs. 96%); the ‘unusual symptoms’ were, however, not explained. 
Most screening units (in 2005 91%, in 2008 93%) informed about a positive result primarily by 
phone, but only two units had guidelines for the content of this phone call. Two screening units sent 
the positive result merely by mail; in 2005 twelve units and in 2008 eight units sent a letter only if 
the woman couldn’t be reached by phone. These letters contained very little information. In 2005 
eight units and in 2008 six units mentioned that most findings turn out to be benign. In 2005 only 
five units told that further investigations are free of charge while in 2008 this was said more often 
(14 units). The letters usually included a phone number for making an appointment; in 2005 four 
letters and in 2008 two letters included a phone number to use if the woman wished to obtain more 
information.
Discussion
According to the guidelines of the European Union, women invited for screening should be fully 
informed about the benefits and risks (3). The evaluation of benefits and harms should be holistic in 
order to reflect consumer priorities (4). Informed consent can be supported by adequate information 
provided before and during the screening. Objective information is important as women easily 
overestimate the effectiveness of screening (5), and women who overestimate the benefits are 
known to participate more actively in screening (6). 
The pros and cons of screening mammography can be presented using age-specific estimates, 
giving women, clinicians and service providers more information about screening (7,8). One way to 
give information is to present benefits and harms graphically, based on national screening results. 
Figure 1 demonstrates the overall effect of breast cancer screening in Finland for women invited for 
6screening over the course of one year. This visual information can help women to consider the 
question “What could happen to me if I participate in screening?”
The data for Figure 1 originate mainly from the Mass Screening Registry in Finland. Data on
participation and further investigations (additional mammography, ultrasound, fine needle biopsy, 
surgery) are means for a five-year period (1999-2003) in women aged 50-59 years. The interval 
cancer rate of breast cancer screening describes the number of cancers not detected (9). We 
calculated the outcome of breast cancers which can be prevented by screening using the average 
mortality rate of Finnish women aged 50-79 (75/100 000) and the average mortality rate from breast 
cancer (22%) from the meta-analysis of USPSTF (10). In Finland, breast cancer screening by 
mammography can thus annually prevent 16.5 breast cancer deaths per 100 000 women invited for 
screening. In other words, breast cancer screening can annually prevent one breast cancer death per 
6060 women in the target group. 
The content of invitation letters in Finland was changed somewhat over three years. At both times, 
we found wide variation between the screening units in the information they provided. The amount 
of detailed information decreased also because the screening units increasingly sent invitations 
centrally, using electronic address systems, which prevented the addition of information leaflets.
The information was biased towards optimizing participation, as most units mentioned the 
possibility of early detection and better prognosis while omitting exact information about incidence. 
Unfortunately, the information doesn’t support an informed decision about participation in 
screening. There is clearly a need for better information in the invitation letters. 
7Our intervention consisted of requesting the information materials, analysing their contents, and 
feeding the summary results back to screening units. This did not improve the quality of the letters. 
During the study years, the mammography technology changed from analogue (film-based) to 
digital imaging, and this resulted in changes of providers as well. The market shift may have 
influenced the capacity and willingness of the units to improve their information materials.
The high participation rate in Finland may partly be due to the prescriptive nature of invitation 
letters. The participation rate can be annually followed through registers and it is possible to see 
whether more transparent information will have an effect on the participation rate.
As the municipalities are responsible for the quality of the screening process, they should ensure
that the information materials are sound and unbiased. The National Screening Board could advise 
the units by providing sample information materials for their use. This will be the next step in 
Finland: Finohta is preparing sample letters for each stage of the screening process at the request of 
the Board. Such templates will support an equitable provision of services and the possibility of true 
informed consent while retaining municipal autonomy.
8Figure 1. Annual general effect of breast cancer screening for 50-59-year-old women in 1999-2003 
in Finland.
Table 1. Performance indicators of breast cancer screening programmes in Finland and Netherlands 
as compared to the guidelines of the European Community
Table 2. Information in the invitation letters (per cents of the screening units in Finland providing 
facts on each item) 
Table 3. The analysed materials (invitation letters, remind letters, result letters and other materials) 
sent by the screening units
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Table 1. Performance indicators of breast cancer screening programmes in 
Finland and Netherlands compared with the guidelines of the European 
community
Performance Indicator Finland
50-69 years
Netherlands
50-69 years
EU 
Guidelines
(desirable 
level)
Attendance rate 90% 79% >75%
Recall rate for further assessment 4.6% 1.3% <5%
Breast cancer detection rate 2.74xIR* 2.95xIR* >3xIR*
Proportion of screen-detective cancers that are
carcinoma in situ
10% 14% 10-20%
Proportion of screen detected cancers  at stage II 33% 20% <20%
Proportion of screen detective invasive cancers 
that are node-negative
>70% 67% 76%
Begingn to malignant biopsy rate <0.5:1 1:1 0,5:1
* IR Incidence rate
Sarkeala T. et la. (2004)
Table
Table 2. Information in the invitation letters (per cents of the screening units in 
Finland providing facts on each item) 
Item 2005
N=23 
2008
N=26 units
Prevalence of breast cancer 26% 15%
Early detection 83% 96%
Better prognosis 78% 88%
Possibility of benign lesions 74% 42%
Positive predictive value 17% 7%
Spesificity of screening 17% 7%
Free of charge 96% 96%
Voluntary participation 9% 7%
Painful procedure 17% 12%
Hormonal therapy 57% 81%
Table
Table 3. The analysed materials (invitation letters, remind letters, result letters 
and other materials) sent by the screening units
Material 2005
(23 units)
2008
(26 units)
Invitation letters 23 26
Reminder letters 7 9
Normal result letter 23 25
Invitation for further investigations 14 10
Other (leaflet) 4 2
Total 71 72
Table
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